Drug Safety Information for DYAZIDE (Hydrochlorothiazide; triamterene)

Safety-related Labeling Changes for DYAZIDE (HYDROCHLOROTHIAZIDE; TRIAMTERENE) Rx Drug: FDA Link

Safety-related Labeling Changes for MAXZIDE (HYDROCHLOROTHIAZIDE; TRIAMTERENE) Rx Drug: FDA Link

Safety-related Labeling Changes for MAXZIDE-25 (HYDROCHLOROTHIAZIDE; TRIAMTERENE) Rx Drug: FDA Link

Adverse Drug Reactions for DYAZIDE* (Hydrochlorothiazide; triamterene)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with DYAZIDE
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Nausea*888
2Fatigue*677
3Pain669
4Dizziness*665
5Dyspnoea650
6Drug ineffective637
7Headache*563
8Asthenia545
9Diarrhoea527
10Oedema peripheral510
11Vomiting444
12Anxiety407
13Fall405
14Arthralgia402
15Hypertension394
16Chest pain386
17Pain in extremity384
18Depression371
19Myocardial infarction358
20Weight decreased345

* This side effect also appears in "Top 10 Side Effects of DYAZIDE " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking DYAZIDE
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Hypertension*6517
2Product used for unknown indication3835
3Oedema*863
4Blood pressure*829
5Fluid retention*639
6Diuretic therapy529
7Swelling297
8Meniere's disease*271
9Oedema peripheral231
10Blood pressure increased206

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for DYAZIDE

Total Reports Filed with FDA: 60752


Number of FDA Adverse Event Reports by Patient Age for DYAZIDE

Total Reports Filed with FDA: 60752*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Hydrochlorothiazide; triamterene (Dyazide, Maxzide, Maxzide-25)

Charts are based on 60752 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and DYAZIDE Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.